JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

Operating Income Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual operating income in 2023 was -32.57 Million CNY , down -5487.44% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly operating income in 2024 Q3 was 23.28 Million CNY , down -25.46% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported an annual operating income of -583.08 Thousand CNY in 2022, down -200.75% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported an annual operating income of 578.76 Thousand CNY in 2021, up 101.76% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly operating income of 5.31 Million CNY for 2024 Q1, up 107.92% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly operating income of 23.28 Million CNY for 2024 Q3, down -25.46% from previous quarter.

Annual Operating Income Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual Operating Income of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year Operating Income Operating Income Growth
2023 -32.57 Million CNY -5487.44%
2022 -583.08 Thousand CNY -200.75%
2021 578.76 Thousand CNY 101.76%
2020 -32.96 Million CNY -122.9%
2019 143.99 Million CNY 175.61%
2018 -190.44 Million CNY -208.17%
2017 176.05 Million CNY 346.88%
2016 39.39 Million CNY -44.69%
2015 71.23 Million CNY -38.9%
2014 116.59 Million CNY -16.05%
2013 138.87 Million CNY 63.0%
2012 85.2 Million CNY 77.75%
2011 47.93 Million CNY 26.84%
2010 37.79 Million CNY 43.87%
2009 26.26 Million CNY 558.85%
2008 -5.72 Million CNY 88.79%
2007 -51.06 Million CNY -335.97%
2006 21.63 Million CNY -67.05%
2005 65.66 Million CNY -32.65%
2004 97.5 Million CNY 27.51%
2003 76.46 Million CNY -2.32%
2002 78.27 Million CNY -18.94%
2001 96.57 Million CNY 90.91%
2000 50.58 Million CNY 26.4%
1999 40.02 Million CNY 24.34%
1998 32.18 Million CNY 7.85%
1997 29.84 Million CNY -12.01%
1996 33.91 Million CNY 0.0%

Peer Operating Income Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name Operating Income Operating Income Difference
Beijing Tiantan Biological Products Co., Ltd. 1.8 Billion CNY 101.805%
Jinyu Bio-technology Co., Ltd. 315.2 Million CNY 110.336%
Vcanbio Cell & Gene Engineering Corp., Ltd 131.12 Million CNY 124.846%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 1.18 Billion CNY 102.75%
Zhejiang Ausun Pharmaceutical Co., Ltd. 290.82 Million CNY 111.203%
DaShenLin Pharmaceutical Group Co., Ltd. 1.63 Billion CNY 101.996%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 1.4 Billion CNY 102.325%
GuiZhou SanLi Pharmaceutical Co.,Ltd 335.82 Million CNY 109.701%
Pulike Biological Engineering, Inc. 193.01 Million CNY 116.879%
Beijing Konruns Pharmaceutical Co.,Ltd. 143.28 Million CNY 122.738%
Shanghai Hile Bio-Technology Co., Ltd. 55.17 Million CNY 159.052%
Qingdao Vland Biotech INC. 122.9 Million CNY 126.509%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 254.72 Million CNY 112.79%
Aurisco Pharmaceutical Co.,Ltd. 330.72 Million CNY 109.851%
Zhejiang East Asia Pharmaceutical Co., Ltd. 136.97 Million CNY 123.786%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 136.93 Million CNY 123.792%
Mabwell (Shanghai) Bioscience Co., Ltd. -1.05 Billion CNY 96.905%
Beijing Hotgen Biotech Co., Ltd. 17.21 Million CNY 289.302%
Assure Tech (Hangzhou) Co., Ltd. 167.48 Million CNY 119.452%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 189.66 Million CNY 117.177%
Cabio Biotech (Wuhan) Co., Ltd. 81.6 Million CNY 139.923%
Shanghai Shen Lian Biomedical Corporation 36.11 Million CNY 190.201%
Nanjing Vazyme Biotech Co., Ltd. -100.18 Million CNY 67.479%
Shandong Kexing Bioproducts Co,.Ltd -254.2 Million CNY 87.184%
Shanghai Junshi Biosciences Co., Ltd. -2.45 Billion CNY 98.674%
Shanghai Model Organisms Center, Inc. -29.8 Million CNY -9.323%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -408.79 Million CNY 92.03%
Xiamen Amoytop Biotech Co., Ltd. 680.72 Million CNY 104.786%
Novogene Co., Ltd. 214.87 Million CNY 115.162%
Shanghai ZJ Bio-Tech Co., Ltd. -149.49 Million CNY 78.207%
Chengdu Olymvax Biopharmaceuticals Inc. 3.4 Million CNY 1057.576%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 318.21 Million CNY 110.238%
Shanghai Haohai Biological Technology Co., Ltd. 507.41 Million CNY 106.421%
Jiangsu Bioperfectus Technologies Co., Ltd. -382.77 Million CNY 91.489%
Jiangsu Aidea Pharmaceutical Co., Ltd. -98.34 Million CNY 66.872%
Chengdu Easton Biopharmaceuticals Co., Ltd. 241.73 Million CNY 113.477%
Sinocelltech Group Limited 6.36 Million CNY 611.806%
Wuhan Keqian Biology Co.,Ltd 459.13 Million CNY 107.096%
Shanghai Allist Pharmaceuticals Co., Ltd. 657.66 Million CNY 104.954%
Anhui Huaheng Biotechnology Co., Ltd. 510.9 Million CNY 106.377%
Youcare Pharmaceutical Group Co., Ltd. 231.75 Million CNY 114.058%
Jiangsu gdk Biotechnology Co., Ltd. -81.67 Million CNY 60.109%
Beijing Kawin Technology Share-Holding Co., Ltd. 170.82 Million CNY 119.072%
Hangzhou Biotest Biotech Co.,Ltd. 116.82 Million CNY 127.888%